1 August 1998 | Volume 129 Issue 3 | Pages 190-196
Background: Although recent advances have been made in the treatment of acute stroke, patients often arrive at the hospital too late to receive the maximum benefit from these new therapies.
Objective: To investigate characteristics that influence the time from symptom onset to hospital arrival (delay time) for patients with acute stroke.
Design: Retrospective medical record review.
Setting: Minneapolis-St. Paul metropolitan hospitals.
Patients: A 50% random sample of all patients 30 to 79 years of age who were hospitalized with acute stroke from 1991 to 1993.
Measurements: Patients were identified through discharge diagnosis lists by using the International Classification of Diseases, 9th Revision. Trained nurses abstracted the medical records. Stroke events were validated by using neuroimaging reports and additional clinical criteria (1895 patients). An accelerated failure time model was used to identify patient characteristics that independently predicted delay time. For 70% of patients (n = 1334), delay time was calculated from the medical record by subtracting the recorded time of symptom onset from the admission time. For the remaining 30% of patients (n = 561), the time of symptom onset was not recorded, and an approximate delay time was estimated from all available information.
Results: Among patients with a calculated delay time, half arrived within 3 hours of symptom onset and 90% arrived within 24 hours. Patients with approximated delay times tended to have longer delays, and less than 40% of these patients arrived within 24 hours of symptom onset. Some characteristics associated (P < 0.05) with longer delay included Asian/Pacific Islander ethnicity, dependence in any activities of daily living before stroke, and several symptoms at stroke onset. Characteristics associated (P < 0.05) with shorter delay included admission through the emergency department, presence of syncope or seizures at stroke onset, previous myocardial infarction, abnormal mental status, and greater disability at presentation (measured by the Rankin scale).
Conclusions: Most patients arrive at the hospital too late to receive the maximum benefit from emerging stroke therapies. Efforts to reduce delays in hospital arrival after acute stroke can maximize the effectiveness of these therapies by specifically targeting persons at risk for longer delay.
Patients with acute stroke often arrive at the hospital too late to receive the maximum benefit from these new stroke therapies. Efforts to reduce delay time of therapy for acute stroke may be more effective if the factors that delay hospital arrival are identified and targeted for specific intervention; however, only a few studies have extensively examined this issue in the United States [6-10]. In contrast, factors influencing hospital arrival time for acute myocardial infarction have been studied in detail [11-21]. Several factors that delay hospital arrival after acute stroke parallel those for acute myocardial infarction, including living alone [8, 12], being at home during symptom onset [7, 11, 12], and first contacting a physician rather than an emergency service [7-9, 12-17]. By using medical record review, we investigated factors that influence the time from stroke onset to patient arrival at metropolitan Minneapolis-St. Paul hospitals.
The Minnesota Stroke Survey is a population-based surveillance study of acute cerebrovascular disease [22]. The target population comprises residents 30 to 79 years of age living in the seven-county metropolitan area of Minneapolis-St. Paul, Minnesota. We report on factors that influenced hospital arrival time during the early 1990s by using combined data from surveys from three calendar years (1991, 1992, and 1993). Discharge diagnosis lists based on the International Classification of Diseases, 9th Revision (ICD-9), stroke codes were obtained from 23 of 25 acute care hospitals in the Minneapolis-St. Paul area for each surveillance year. The two hospitals that did not provide data have low patient volume (an estimated two to four valid patients with stroke per hospital per year). The sampling frame included all Minneapolis-St. Paul residents 30 to 79 years of age who were discharged with an acute cerebrovascular disease code (ICD-9 codes 430, 431, 432, 434, 436, and 437). For each surveillance year, a 50% random sample was selected from the listings for detailed record abstraction. No data were available for patients who were not hospitalized. Previous studies have estimated that 81% of all patients with a first stroke event were hospitalized, and patients with fatal strokes were less likely to be hospitalized than those with nonfatal strokes (76% and 89%, respectively) [23].
Data Collection
Trained nurses used standardized data collection forms to abstract clinical data from the medical record, including date and time of symptom onset, data and time of admission to the hospital, demographic characteristics, medical history, symptoms at stroke onset, physician examination findings, stroke severity, and stroke type. Neuroimaging and autopsy reports were photocopied and abstracted by study physicians who did not have knowledge of the patient's other medical record data. The study was approved by the institutional review board of the University of Minnesota.
Stroke Validation and Classification
Because factors influencing delay time were assumed to be unrelated to stroke type, we included all stroke types in the sample. Events were included when the patient had a new neurologic deficit that lasted at least 24 hours or until death. Patients with brain tumors, subdural hematomas, and subarachnoid hemorrhages were excluded. Autopsy results were available for only 9% of patients who died while they were hospitalized. Accordingly, autopsy results were used to confirm the diagnosis of stroke for less than 1% of patients (n = 16). Stroke events were classified as "hemorrhagic" or "ischemic" on the basis of neuroimaging results and autopsy reports or as "undetermined" when neither data source was available. Ischemic stroke was divided into "possibly embolic" and "nonembolic" subtypes. A stroke was considered possibly embolic if ICD-9 code 434.1 (cerebral embolism) was listed among the discharge diagnoses, if the medical record indicated that the stroke was definitely or probably embolic (including embolism from the carotid arteries), or if one or more of the following conditions was documented in the medical record: atrial fibrillation, mitral stenosis, intracardiac thrombus, systemic embolus, recent myocardial infarction, or cerebral or cardiac angiography that closely preceded the stroke.
Patients were excluded if symptoms developed while the patient was hospitalized for another condition (n = 294) or if the patient had been transferred from another hospital (n = 41). During the initial stages of the medical record abstraction, we did not collect information on whether the patient was admitted to the hospital through the emergency department; these patients were also excluded (n = 216). At the time of analysis, data collection was 77% complete. The final available sample size was 1895 hospitalizations for acute stroke.
Variables
The main variable of interest, delay time, was defined as the time from the onset of new neurologic symptoms to the time of hospital arrival. Time of hospital arrival was defined as the time the patient presented to the emergency department or the hospital (if the patient was not admitted through the emergency department). The time of symptom onset was recorded in the medical record of 70% of the patients (n = 1334). The delay time was calculated by subtracting the recorded time of symptom onset from the hospital arrival time when both times were available. For the remaining patients (n = 561), the time of symptom onset was not recorded in the medical record; therefore, we approximated the delay time on the basis of all available information (<24 hours,
Demographic characteristics included age, sex, and ethnicity. Ethnicity was categorized as white, African American, Asian/Pacific Islander, and other. We also identified whether the patient was enrolled in a health maintenance organization, whether the patient lived alone or in a nursing home before the stroke, whether do-not-resuscitate or do-not-intubate orders existed before hospital admission, and whether the patient was admitted to the hospital through the emergency department. A history of the following conditions was recorded: transient ischemic attack, stroke, myocardial infarction, diabetes, hypertension, hypercholesterolemia, whether the patient ever smoked, and daily use of aspirin or warfarin. The level of comorbidity was estimated by using a modified Charlson comorbidity index, excluding two conditions specific to acute stroke (cerebrovascular disease and hemiplegia) [24]. The patient's prestroke functional status was measured by determining whether the patient was dependent in at least one activity of daily living (bathing, continence, feeding, going to the toilet, and transfer into or out of a bed or chair) before the onset of the stroke [25].
The presence of the following symptoms at stroke onset was recorded: limb or facial weakness, impaired speech, impaired vision, dizziness, unsteadiness, tingling, seizures, syncope, headache, and vomiting. The time of symptom onset was classified by the quarter of the day that the stroke occurred (morning = 6 a.m. to noon, afternoon = noon to 6 p.m., evening = 6 p.m. to midnight, night = midnight to 6 a.m.). The date of symptom onset was used to characterize whether the stroke occurred on a weekend (Saturday or Sunday).
Several variables were used to indicate the severity of the stroke at presentation. The level of consciousness was assigned one of three categories (unconscious, conscious but abnormal, or normal). The level of disability was estimated by using the Rankin score (from 1 = no disability to 5 = severe disability) [26]. The following findings on physician examination were also noted: weakness or paralysis of the limbs and face, visual defects, ataxia, sensory loss, aphasia, dysarthria, impaired swallowing, abnormal findings on pupil examination, and abnormal plantar (Babinski) reflex.
Statistical Analysis
Parametric survival regression analysis based on an accelerated failure time model was used to examine the influence of the explanatory variables on delay time. Patients with a calculated delay time were treated as uncensored data. Patients with an approximated delay time that indicated arrival within 24 hours of symptom onset were treated as left-censored at 24 hours. Patients with an approximated delay time that indicated arrival within 24 to 48 hours, 48 to 72 hours, and 72 hours to 6 weeks were treated as interval-censored data. The generalized
The characteristics of the study patients are shown in Table 1. The mean age was 66 years, and almost half of the sample was female. Eighty-eight percent of the patients were white, 7% were African American, and 2% were Asian/Pacific Islander. One quarter of the patients lived at home alone, and almost half were enrolled in a health maintenance organization. Most patients had a history of another important medical condition. Almost half of patients had a history of transient ischemic attack or stroke, and one quarter had a history of diabetes. One quarter of patients were receiving a daily dose of aspirin before admission; 1 in 10 was receiving warfarin. The mean value of the Charlson comorbidity index was 1.7 (range, 0 to 12), indicating that many patients had at least one additional medical condition that was important enough to influence survival during hospitalization. One quarter of patients were dependent in at least one activity of daily living before symptom onset, and 1 in 20 had do-not-resuscitate or do-not-intubate orders before admission to the hospital. ARTICLE
Delayed Hospital Arrival for Acute Stroke: The Minnesota Stroke Survey
Recent advances have been made in the treatment of acute stroke, but the effectiveness of the new therapies is highly time-dependent [1]. For example, the American Heart Association guidelines recommend the use of thrombolytic therapy with tissue plasminogen activator for a subset of patients with acute ischemic stroke, but this agent must be administered within 3 hours after the onset of stroke to be effective [2-5]. The effectiveness of tissue plasminogen activator diminishes with time; the longer the delay, the smaller the probability of improving blood flow to the affected area of the brain and the greater the risk for hemorrhagic complications [3].
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Sample Selection
24 hours to <48 hours,
48 hours to <72 hours, and
72 hours to <6 weeks).
model and three models nested within the generalized
model (exponential, Weibull, and log-normal models) were compared by using the likelihood ratio statistic. The two best-fitting models were the generalized
model and the log-normal model. The conclusions did not differ between the two models, and the results from the log-normal model are presented. The ß coefficients estimated from this model were converted to the percentage difference in delay time associated with a one-unit increment in the explanatory variable X [% Delta Delay/Delta X = (eß- 1) x 100]. For continuous variables, this value indicates the percentage difference in delay time associated with a one-unit increment in the explanatory variable. For indicator variables, this value indicates the percentage difference in delay time in the presence of the indicator. The data were analyzed by using SAS PROC LIFEREG [27]. Because the delay times for patients may have been clustered within hospitals, we also used a mixed-effects model (SAS PROC MIXED) to examine clustering by hospital for the 70% of cases with calculated delay times (data not shown). We found no evidence of within-hospital correlations (intraclass correlation coefficient, 0.000), and SEs were almost identical to the results obtained with the fixed-effects model.
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Patient Characteristics
|
The timing of symptom onset was not evenly distributed. Fewer strokes occurred at night, and most strokes occurred in the morning. Most patients (81%) were admitted to the hospital through the emergency department. Limb or facial weakness was the most prevalent symptom at stroke onset (69%), although most patients also had speech impairment (56%). One third of patients developed unsteadiness, and one quarter reported tingling sensations. Seizures and syncope were relatively rare (<4% of patients). Headache and vomiting were present in one fifth and one tenth of patients, respectively.
The mean Rankin score was 3.4 ± 1.0, indicating that most patients had substantial disability on presentation. Eleven percent of patients were unconscious, and 42% were conscious but had some degree of abnormal mentation. Arm weakness or paralysis was the most common neurologic deficit identified on physician examination; this condition was present in two thirds of patients. Less than half of patients had dysarthria, and approximately one third had aphasia, sensory loss, and ataxia. One fifth of patients had visual field defects, and one quarter had an abnormal result on pupil examination. Almost half of all patients had an abnormal plantar (Babinski) reflex. Finally, 11% of patients were classified as having had hemorrhagic stroke, 85% as having had ischemic stroke, and 4% as having had a stroke of undetermined type. One third of strokes were possibly embolic, and more than half were nonembolic.
Delay Time to Hospital Arrival
Figure 1 shows the delay time for all patients in broad categories. Patients with approximated delay times tended to have longer delays, and less than 40% of patients arrived within 24 hours of symptom onset. In contrast, 90% of patients with calculated delay times arrived within 24 hours of symptom onset. For the 70% of patients with calculated delay times, Figure 2 gives more precise categories of delay times. Approximately half of these patients arrived within 3 hours of symptom onset, and two thirds arrived within 6 hours.
|
|
Patient Characteristics Predicting Delay Time
Table 2 shows the patient characteristics that independently predicted delay time. Asian/Pacific Islander patients had a 107% longer delay time than white patients. Patients with dependence in any activity of daily living before the stroke had a 36% longer delay time compared with patients who were independent in all five activities of daily living. Three symptoms (impaired vision, unsteadiness, and headache) were independently associated with longer delay. Finally, patients who did not have the time or day of symptom onset recorded in the medical record had substantially longer delay times. For example, patients for whom the time of symptom onset was not recorded in the medical record had a 383% longer delay than patients for whom the time of symptom onset was recorded. Three other characteristics reached borderline statistical significance: history of diabetes, preexisting do-not-resuscitate or do-not-intubate order, and ataxia at presentation.
|
Several patient characteristics were associated with shorter delay. Delay time was substantially shorter with admission through the emergency department (46%). Other characteristics associated with shorter delay included syncope or seizures at stroke onset; possibly embolic, hemorrhagic, or undetermined stroke type; and a history of myocardial infarction. Increasing disability at presentation (measured by the Rankin score) was linked to shorter delay. Patients who were conscious but had abnormal mental status had a 16% shorter delay than patients whose mental status was normal. Unconsciousness at presentation, female sex, tingling at stroke onset, and visual defect and dysarthria as determined by physician examination were of borderline statistical significance.
Eighteen observations were identified that potentially influenced the fit of the model. The conclusions were similar after the analysis was done without these observations. The single discrepancy was that higher levels of the comorbidity index were associated with longer delay. For each unit increment in the comorbidity index, the model predicted a 4% longer delay time (95% CI, 0% to 8%).
Discussion
|
|---|
|
|
|---|
Effective public health interventions to reduce delay time should be based on an understanding of the factors that delay hospital arrival for acute stroke patients. In our study, ethnicity was an important patient characteristic that predicted delayed hospital arrival. In particular, patients of Asian/Pacific Islander descent had substantially longer delay than white patients, although the absolute number of Asian/Pacific Islander patients in this sample was small. The lack of a statistically significant difference for patients from other ethnic groups may also reflect the relatively small numbers of these patients. One study of acute stroke did not find an association with ethnicity [7], but longer delays have been shown for African-American and Hispanic patients with acute myocardial infarction [13, 16]. Longer delay may arise from cultural factors or the lack of a usual care provider [28, 29]. Patient age and sex were also not significant factors influencing delay time in this analysis, although female sex was associated with shorter delay and was of borderline statistical significance. Although one study of stroke suggested that increasing age might be associated with longer delay [8], that study did not control for potentially confounding variables, such as previous functional dependence among older patients. In contrast, both older age and female sex have been associated with longer delay for presentation with myocardial infarction [11, 12, 15, 19, 30].
Members of health maintenance organizations were not less likely to delay hospital arrival. Some managed care settings require patients to obtain authorization before visiting the emergency department, and these regulations have been seen as a potential barrier to rapid emergency care for patients with the symptoms of acute and potentially life-threatening disease [20]. However, we found no evidence that managed care contributed to increased delay for patients with acute symptoms of stroke.
Patients with preexisting health concerns (such as dependence in activities of daily living or comorbid conditions) also had longer delay times. Stroke can present with a bewildering array of symptoms, and new symptoms of acute stroke might be mistakenly interpreted by some patients as related to preexisting health problems [18, 31]. Similar results were reported for acute myocardial infarction, in which a history of cardiac risk factors (such as diabetes) lengthened delay [30]. It is also possible that dependence in activities of daily living (such as feeding or transfer) interferes with the ability to seek care for new symptoms [18].
Milder and less visible symptoms may also lengthen the delay in seeking medical attention [18]. Symptom severity is important for patients with myocardial infarction, and shorter delays have been described for patients with more severe symptoms [17]. Patients with milder strokes had substantially longer delay, as assessed by the Rankin disability score at presentation. Various symptoms at stroke onset also delayed arrival at the hospital, including impaired vision, unsteadiness, and headache. Syncope and seizures were associated with shorter delay. Unsteadiness and headache occur in a wide array of nonspecific and non-life-threatening medical conditions. Patients may consider these symptoms less serious and delay longer as a consequence. In contrast to these results, an earlier study suggested that headache and vomiting shortened delay, probably because these symptoms are associated with the onset of hemorrhagic stroke [9]. However, we controlled for stroke type and for several measures of stroke severity.
Familiarity with stroke symptoms and the consequences of stroke may also influence delay time [18], but recent evidence suggests that knowledge alone is not enough to change care-seeking behavior [10]. We found no evidence of shorter delay for patients with previous transient ischemic attack or stroke or daily use of aspirin or warfarin. A similar result has been found for acute myocardial infarction, in which a history of coronary heart disease did not reduce delay [15, 20, 30]. Of interest, previous myocardial infarction was associated with shorter delay for these patients with stroke, but previous stroke was not.
These data are consistent with research showing delayed hospital arrival for infarction compared with hemorrhagic stroke [6, 9]. In our analysis, hemorrhagic and possibly embolic strokes were associated with shorter delays. The more dramatic and abrupt onset of hemorrhagic and embolic strokes may explain this finding [6, 9]. Another finding similar to that of previous studies of stroke and myocardial infarction was that nonemergency admission delayed arrival after the onset of acute stroke [7, 9, 12, 14, 17, 20]. We did not find evidence that living alone, nocturnal onset, or weekend onset influenced delay, although these factors have been shown to increase stroke delay time in other studies [7-9]. The large number of variables analyzed may explain this apparent discrepancy. For example, chronobiological variation in acute stroke may be associated with variables (such as stroke type) for which we controlled in this analysis [32].
Several limitations of our study deserve mention. First, although a time of symptom onset was available in the medical record for 70% of patients, this recorded time is susceptible to measurement error by both patients and providers. For the remaining 30% of patients, only an approximate time was available. Although the inclusion of all patients in the regression model was a major strength of our analysis, the lack of a precisely measured time of symptom onset merits a cautionary note. Second, no information was available about whether the patient was at home or at another location when the stroke occurred. In both myocardial infarction and stroke, symptom onset at home has been associated with delayed hospital arrival [7, 12]. Finally, these data are more than 4 years old, and patterns of delay time may have evolved. However, no widespread public education efforts to reduce delay time for acute stroke have been made in recent years, and no evidence exists that delay times have changed greatly.
Many patients with stroke arrive at the hospital too late to receive the maximum benefit from medical care. Although only a few patients with acute stroke will probably be eligible for thrombolytic therapy, many other advances in diagnosis and treatment have improved care for stroke [33, 34]. Early neurologic attention has been related to improved functional outcome and shorter hospitalization [35]. Rapid emergency care and admission to a hospital unit that specializes in cerebrovascular disease is currently recommended for all patients with acute stroke [33, 34]. Efforts to reduce delays in hospital arrival can maximize the effectiveness of therapy by specifically targeting persons at risk for longer delay. As a result, more patients should become eligible for new stroke therapies that require early administration or for enrollment in clinical trials of the benefits of emerging stroke therapies.
From the School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Drs. Doliszny, Shahar, McGovern, Arnett, and Luepker: Division of Epidemiology, School of Public Health, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454-1015.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Barinaga M. Finding new drugs to treat stroke. Science. 1996; 272:664-6.
2. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996; 27:1711-8.
3. Hachinski V. Thrombolysis in stroke: between the promise and the peril [Editorial]. JAMA. 1996; 276:995-6.
4. Pincus MM. Thrombolysis for stroke [Letter]. JAMA. 1997; 277:19-20.
5. Dorman P, Sandercock P. TPA within 3 hours of acute ischaemic stroke? Lancet. 1996; 348:1600-1.
6. Alberts MJ, Bertels C, Dawson DV. An analysis of time of presentation after stroke. JAMA. 1990; 263:65-8.
7. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marler JR. Time of hospital presentation in patients with acute stroke. Arch Intern Med. 1993; 153:2558-61.
8. Harper GD, Haigh RA, Potter JF, Castleden CM. Factors delaying hospital admission after stroke in Leicestershire. Stroke. 1992; 23:835-8.
9. Fogelholm R, Murros K, Rissanen A, Ilmavirta M. Factors delaying hospital admission after acute stroke. Stroke. 1996; 27:398-400.
10. Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med. 1998; 5:45-51.
11. Turi ZG, Stone PH, Muller JE, Parker C, Rude RE, Raabe DE, et al. Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol. 1986; 58:203-9.
12. Alonzo AA. The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease. Soc Sci Med. 1986; 22:1297-311.
13. Clark LT, Bellam SV, Shah AH, Feldman JG. Analysis of prehospital delay among inner-city patients with symptoms of acute myocardial infarction: implications for therapeutic intervention. J Natl Med Assoc. 1992; 84:931-7.
14. Schroeder JS, Lamb IH, Hu M. The prehospital course of patients with chest pain. Analysis of the prodromal, symptomatic, decision-making, transportation and emergency room periods. Am J Med. 1978; 64:742-8.
15. Moss AJ, Wynar B, Goldstein S. Delay in hospitalization during the acute coronary period. Am J Cardiol. 1969; 24:659-65.
16. Dracup K, Moser DK, Eisenberg N, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med. 1995; 40:379-92.
17. Kenyon LW, Ketterer MW, Gheorghiade M, Goldstein S. Psychological factors related to prehospital delay during acute myocardial infarction. Circulation. 1991; 84:1969-76.
18. Mechanic D. Medical Sociology. 2d ed. New York: Free Pr; 1978.
19. Schmidt SB, Borsch MA. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol. 1990; 65:1411-5.
20. Dracup K, Alonzo AA, Atkins JM, Bennett NM, Braslow A, Clark LT, et al. The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med. 1997; 126:645-51.
21. Gurwitz JH, McLaughlin TJ, Willison DJ, Guadagnoli E, Hauptman PJ, Gao X, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997; 126:593-9.
22. Shahar E, McGovern PG, Pankow JS, Doliszny KM, Smith MA, Blackburn H, et al. Stroke rates during the 1980s. The Minnesota Stroke Survey. Stroke. 1997; 28:275-9.
23. Leibson CL, Naessens JM, Brown RD, Whisnant JP. Accuracy of hospital discharge abstracts for identifying stroke. Stroke. 1994; 25:2348-55.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-83.
25. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963; 185:914-9.
26. Rankin J. Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scott Med J. 1957; 2:200-15.
27. SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute, Inc.; 1989.
28. Harrison I, Harrison D. The black family experience and health behavior. In: Crawford CO, ed. Health and the Family: A Medical-Sociological Analysis. New York: Macmillan; 1971.
29. Weissman JS, Stern R, Fielding SL, Epstein AM. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med. 1991; 114:325-31.
30. Moss AJ, Goldstein S. The pre-hospital phase of acute myocardial infarction. Circulation. 1970; 41:737-42.
31. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet. 1982; 1:328-31.
32. Gallerani M, Manfredini R, Ricci L, Cocurullo A, Goldoni C, Bigoni M, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand. 1993; 87:482-7.
33. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994; 25:1901-14.[Medline]
34. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993; 342:395-8.
35. Davalos A, Castillo J, Martinez-Vila E. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke. 1995; 26:2233-7.
Related articles in Annals:
This article has been cited by other articles:
![]() |
L G Stead, L Vaidyanathan, M F Bellolio, R Kashyap, A Bhagra, R M Gilmore, W W Decker, S Enduri, S Suravaram, S Mishra, et al. Knowledge of signs, treatment and need for urgent management in patients presenting with an acute ischaemic stroke or transient ischaemic attack: a prospective study Emerg. Med. J., November 1, 2008; 25(11): 735 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hodgson, P. Lindsay, and F. Rubini Can Mass Media Influence Emergency Department Visits for Stroke? Stroke, July 1, 2007; 38(7): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chitravas, H. M. Dewey, M. B. Nicol, D. L. Harding, D. C. Pearce, and A. G. Thrift Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology, May 15, 2007; 68(20): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Moser, L. P. Kimble, M. J. Alberts, A. Alonzo, J. B. Croft, K. Dracup, K. R. Evenson, A. S. Go, M. M. Hand, R. U. Kothari, et al. Reducing Delay in Seeking Treatment by Patients With Acute Coronary Syndrome and Stroke: A Scientific Statement From the American Heart Association Council on Cardiovascular Nursing and Stroke Council Circulation, July 11, 2006; 114(2): 168 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.G. Gonzalez Imaging-guided acute ischemic stroke therapy: From "time is brain" to "physiology is brain". AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 728 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Stansbury, H. Jia, L. S. Williams, W. B. Vogel, and P. W. Duncan Ethnic Disparities in Stroke: Epidemiology, Acute Care, and Postacute Outcomes Stroke, February 1, 2005; 36(2): 374 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lorberboym, Y. Lampl, and M. Sadeh Correlation of 99mTc-DTPA SPECT of the Blood-Brain Barrier with Neurologic Outcome After Acute Stroke J. Nucl. Med., December 1, 2003; 44(12): 1898 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stahl, K. L. Furie, S. Gleason, and G. S. Gazelle Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations Radiology, September 1, 2003; 228(3): 659 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fassbender, S. Walter, Y. Liu, F. Muehlhauser, A. Ragoschke, S. Kuehl, and O. Mielke "Mobile Stroke Unit" for Hyperacute Stroke Treatment Stroke, June 1, 2003; 34 (6): e44 - e44. [Full Text] [PDF] |
||||
![]() |
S. U. Lattimore, J. Chalela, L. Davis, T. DeGraba, M. Ezzeddine, J. Haymore, P. Nyquist, A. E. Baird, J. Hallenbeck, and S. Warach Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy: The NINDS Suburban Hospital Stroke Center Experience Stroke, June 1, 2003; 34 (6): e55 - e57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fisher Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 Stroke, June 1, 2003; 34(6): 1539 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Harraf, A. K Sharma, M. M Brown, K. R Lees, R. I Vass, and L. Kalra A multicentre observational study of presentation and early assessment of acute stroke BMJ, July 6, 2002; 325(7354): 17 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Derex, P. Adeleine, N. Nighoghossian, J. Honnorat, and P. Trouillas Factors Influencing Early Admission in a French Stroke Unit Stroke, January 1, 2002; 33(1): 153 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sug Yoon, R. F. Heller, C. Levi, J. Wiggers, and P. E. Fitzgerald Knowledge of Stroke Risk Factors, Warning Symptoms, and Treatment Among an Australian Urban Population Stroke, August 1, 2001; 32(8): 1926 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Localio, J. A. Berlin, T. R. Ten Have, and S. E. Kimmel Adjustments for Center in Multicenter Studies: An Overview Ann Intern Med, July 17, 2001; 135(2): 112 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Barthel, S. Hesse, C. Dannenberg, A. Rossler, D. Schneider, W. H. Knapp, J. Dietrich, and J. Berrouschot Prospective Value of Perfusion and X-Ray Attenuation Imaging With Single-Photon Emission and Transmission Computed Tomography in Acute Cerebral Ischemia Stroke, July 1, 2001; 32(7): 1588 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kissela, J. Broderick, D. Woo, R. Kothari, R. Miller, J. Khoury, T. Brott, A. Pancioli, E. Jauch, J. Gebel, et al. Greater Cincinnati/Northern Kentucky Stroke Study : Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study Editorial Comment : The Greater Cincinnati/Northern Kentucky Stroke Study: Volume of First-Ever Ischemic Stroke Among Black Americans in a Population-Based Study Stroke, June 1, 2001; 32(6): 1285 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Chalela, I. Katzan, D. S. Liebeskind, P. Rasmussen, O. Zaidat, J. I. Suarez, D. Chiu, R. P. Klucznick, E. Jauch, B. L. Cucchiara, et al. Safety of Intra-Arterial Thrombolysis in the Postoperative Period Editorial Comment : Safety of Intra-Arterial Thrombolysis in the Postoperative Period Stroke, June 1, 2001; 32(6): 1365 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Johnston, L. H. Fung, L. A. Gillum, W. S. Smith, L. M. Brass, J. H. Lichtman, A. N. Brown, and D. Z. Wang Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers : The Influence of Ethnicity Editorial Comment : It Is Time to Implement Stroke Practice Improvement Programs and Prevent the Racial Disparity in Stroke Care Stroke, May 1, 2001; 32(5): 1061 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uchino, D. Billheimer, and S. C. Cramer Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials Stroke, April 1, 2001; 32(4): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Lacy, D.-C. Suh, M. Bueno, and J. B. Kostis Delay in Presentation and Evaluation for Acute Stroke : Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.) Stroke, January 1, 2001; 32(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Morris, W. Rosamond, K. Madden, C. Schultz, and S. Hamilton Prehospital and Emergency Department Delays After Acute Stroke : The Genentech Stroke Presentation Survey Stroke, November 1, 2000; 31(11): 2585 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Wein, L. Staub, R. Felberg, S. L. Hickenbottom, W. Chan, J. C. Grotta, A. M. Demchuk, J. Groff, L. K. Bartholomew, and L. B. Morgenstern Activation of Emergency Medical Services for Acute Stroke in a Nonurban Population : The T.L.L. Temple Foundation Stroke Project Stroke, August 1, 2000; 31(8): 1925 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Lacy, M. Bueno, and J. B. Kostis Delayed Hospital Arrival for Acute Stroke Ann Intern Med, February 16, 1999; 130(4_Part_1): 328 - 328. [Full Text] [PDF] |
||||
![]() |
J. H. Lichtman, H. M. Krumholz, Y. Wang, M. J. Radford, and L. M. Brass Risk and Predictors of Stroke After Myocardial Infarction Among the Elderly: Results From the Cooperative Cardiovascular Project Circulation, March 5, 2002; 105(9): 1082 - 1087. [Abstract] [Full Text] [PDF] |
||||
|